Shinobi Therapeutics, a pioneering biotech firm dedicated to revolutionizing cancer treatment, has successfully raised $59 million in its latest funding round. This significant capital infusion will bolster the company鈥檚 innovative mission of developing hypoimmune CD8ab induced pluripotent stem cells (iPS-T cells), which are engineered to evade the immune system while effectively targeting malignant cells. By harnessing the power of immune evasion, Shinobi aims to unlock the therapeutic potential of iPSCs, addressing not only cancer but a variety of other serious medical conditions. The funding will be used to advance the company's research and development efforts, culminating in preclinical and clinical trials that validate the efficacy and safety of these groundbreaking therapies. With the support of investors who share their vision, Shinobi Therapeutics is poised to make significant strides in the field of immunotherapy, potentially transforming the lives of patients battling cancer and beyond. This funding marks a pivotal moment in Shinobi's growth trajectory, allowing the company to expand its team, enhance its technological capabilities, and forge crucial partnerships within the industry. As it moves forward, Shinobi Therapeutics remains committed to innovation, aiming to not only improve treatment outcomes but also redefine the way we approach immune-related therapies in the future.
Shinobi Therapeutics Secures $59 Million in Funding for Groundbreaking Cancer Treatment Innovation
Recently funded 路 $59.0MBiotechnology Research
Get the full Shinobi Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
